PMID: 8952780Nov 1, 1996Paper

Gene therapy of nervous system diseases in children

Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie
P Gressens

Abstract

Gene therapy seems very promising for numerous diseases of the developing nervous system of infants. The efficacy of such an approach relies on different parameters: 1) choice of a target gene; 2) selection of a promoter permitting a robust and protracted expression of the delivered gene in the target cells; 3) selection of a vector permitting to deliver the gene to the right cells with efficacy and without side-effects; 4) choice of the way to administer the vector to the target cells. Although experimental and methodological tools have greatly improved during the last decade, gene therapy of child nervous system diseases is still in the field of basic research.

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

The New Zealand Medical Journal
Martin Wilkinson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Tal Grenader, Alberto Gabizon
Zeitschrift für medizinische Laboratoriumsdiagnostik
C MetznerR Kätzel
© 2021 Meta ULC. All rights reserved